Review



serca2a aav1  (Celladon Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Celladon Inc serca2a aav1
    Gene therapy approaches in various neurological disorders
    Serca2a Aav1, supplied by Celladon Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/aav1%2Eserca2a/pmc08518903-384-7-0?v=Celladon+Inc
    Average 90 stars, based on 1 article reviews
    serca2a aav1 - by Bioz Stars, 2026-07
    90/100 stars

    Images

    1) Product Images from "Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases"

    Article Title: Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases

    Journal: Molecular Neurobiology

    doi: 10.1007/s12035-021-02555-y

    Gene therapy approaches in various neurological disorders
    Figure Legend Snippet: Gene therapy approaches in various neurological disorders

    Techniques Used: Transgenic Assay, Mouse Assay, Over Expression, Inhibition, Activity Assay, Migration, Expressing, Functional Assay, Activation Assay, Plasmid Preparation, Injection, Recombinant, shRNA, CRISPR



    Similar Products

    serca2a aav1  (Celladon Inc)
    90
    Celladon Inc serca2a aav1
    Gene therapy approaches in various neurological disorders
    Serca2a Aav1, supplied by Celladon Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/aav1%2Eserca2a/pmc08518903-384-7-0?v=Celladon+Inc
    Average 90 stars, based on 1 article reviews
    serca2a aav1 - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    aav1.serca2a  (uniQure Inc)
    90
    uniQure Inc aav1.serca2a
    Gene therapy approaches in various neurological disorders
    Aav1.Serca2a, supplied by uniQure Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/aav1%2Eserca2a/pmc07544018-169-8-16?v=uniQure+Inc
    Average 90 stars, based on 1 article reviews
    aav1.serca2a - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    aav1/serca2a  (Celladon Inc)
    90
    Celladon Inc aav1/serca2a
    <t> AAV1 </t> NAb titers in non-immunosuppressed and immunosuppressed mini-pigs
    Aav1/Serca2a, supplied by Celladon Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/aav1%2Eserca2a/pmc06558655-198-34-36?v=Celladon+Inc
    Average 90 stars, based on 1 article reviews
    aav1/serca2a - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    aav1/serca2a vials  (Celladon Inc)
    90
    Celladon Inc aav1/serca2a vials
    <t> AAV1 </t> NAb titers in non-immunosuppressed and immunosuppressed mini-pigs
    Aav1/Serca2a Vials, supplied by Celladon Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/aav1%2Eserca2a/pm28393439-34-2-7?v=Celladon+Inc
    Average 90 stars, based on 1 article reviews
    aav1/serca2a vials - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    aav1.serca2a  (Celladon Inc)
    90
    Celladon Inc aav1.serca2a
    <t> AAV1 </t> NAb titers in non-immunosuppressed and immunosuppressed mini-pigs
    Aav1.Serca2a, supplied by Celladon Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/aav1%2Eserca2a/pmc05999331-467-36-30?v=Celladon+Inc
    Average 90 stars, based on 1 article reviews
    aav1.serca2a - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    aav1/serca2a tgabg12  (Targeted Genetics Corporation)
    90
    Targeted Genetics Corporation aav1/serca2a tgabg12
    <t> AAV1 </t> NAb titers in non-immunosuppressed and immunosuppressed mini-pigs
    Aav1/Serca2a Tgabg12, supplied by Targeted Genetics Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/aav1%2Eserca2a/pmc05843948-204-6-13?v=Targeted+Genetics+Corporation
    Average 90 stars, based on 1 article reviews
    aav1/serca2a tgabg12 - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Gene therapy approaches in various neurological disorders

    Journal: Molecular Neurobiology

    Article Title: Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases

    doi: 10.1007/s12035-021-02555-y

    Figure Lengend Snippet: Gene therapy approaches in various neurological disorders

    Article Snippet: Celladon utilized intracoronary infusion to administer the SERCA2A AAV1 product, whereas UniQure utilizes retro-infusion as well as left anterior descending coronary occlusion [ , ].

    Techniques: Transgenic Assay, Mouse Assay, Over Expression, Inhibition, Activity Assay, Migration, Expressing, Functional Assay, Activation Assay, Plasmid Preparation, Injection, Recombinant, shRNA, CRISPR

    AAV1 NAb titers in non-immunosuppressed and immunosuppressed mini-pigs

    Journal: Gene therapy

    Article Title: Prevalence of AAV1 neutralizing antibodies and consequences for a clinical trial of gene transfer for advanced heart failure

    doi: 10.1038/gt.2015.109

    Figure Lengend Snippet: AAV1 NAb titers in non-immunosuppressed and immunosuppressed mini-pigs

    Article Snippet: Three of the 39 patients enrolled in this trial seroconverted to detectable NAb levels between NAb screening (up to 6 months before day of dosing) and day 0, and received a single infusion of AAV1/SERCA2a (MYDICAR, Celladon Corporation, San Diego, CA, USA) or placebo.

    Techniques: Control